tiprankstipranks
AstraZeneca, Daiichi Sankyo announce Enhertu recommended for EU approval
The Fly

AstraZeneca, Daiichi Sankyo announce Enhertu recommended for EU approval

Daiichi Sankyo and AstraZeneca’s Enhertu has been recommended for approval in the European Union as a monotherapy for the treatment of adult patients with advanced HER2 positive gastric or gastroesophageal junction, or GEJ, adenocarcinoma who have received a prior trastuzumab-based regimen.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on AZN:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles